Content about George Paz

WHAT IT MEANS AND WHY IT'S IMPORTANT — "I appreciate the fact that [Walgreens is] trying to do some very good things with respect to clinical offerings and other avenues to try to impact the overall healthcare spectrum. But quite frankly, that hasn't been proven to reduce cost." That was what George Paz, Express Scripts chairman, president and CEO, said Thursday morning about the go-to-market strategy currently being employed by Walgreens. Later that day, Walgreens released these data — contrary to Paz's take on the value of Walgreens.

WHAT IT MEANS AND WHY IT'S IMPORTANT — It's been a big week for Walgreens. Following its exit from Express Scripts' pharmacy network, the pharmacy retailer introduced a new program to help patients either keep their pharmacy home at Walgreens or to help transition them to a new pharmacy. Why help transition customers to the competition? Because it's the right thing to do. As Greg Wasson told DSN editor Rob Eder in an exclusive interview, "our No. 1 priority is to take care of patients."

ALEXANDRIA, Va. — The National Association of Chain Drug Stores on Wednesday challenged some of Express Scripts' and Medco's testimony during last week's hearing before the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, most notably that PBMs are subject to state regulation in all states and that as a PBM the two companies have no influence on the design of prescription drug benefits.

WASHINGTON — George Paz, Express Scripts chairman and CEO, and David Snow, Medco Health Solutions chairman and CEO, were in a pair of hot seats Tuesday afternoon before the Senate Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Many of the questions posed by Senators on the subcommittee challenged the respective chief executives on how the proposed merger would negatively impact retail pharmacy and how the proposed merger would result in a dominant marketshare of the mail order pharmacy business.